← Browse by Condition
Medical Condition

chronic obstructive pulmonary disease

Total Trials
11
Recruiting Now
11
Trial Phases
Phase 2, Phase 1, Phase 2
NCT06330623
Recruiting

Developing Personalised Relative Physical Activity Thresholds in COPD.

Enrollment
70 pts
Location
United Kingdom
Sponsor
University of Leicester
View Trial →
NCT06381973
Recruiting

Ventilation Distribution in COPD Patients During Breathing Exercises

Enrollment
50 pts
Location
Belgium
Sponsor
William Poncin, PT, PhD
View Trial →
NCT05937854 Phase 2
Recruiting

Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH

Enrollment
126 pts
Location
United States
Sponsor
VA Office of Research and Deve...
View Trial →
NCT00307281
Recruiting

Emphysema Research Registry and Biosample Repository

Enrollment
3,000 pts
Location
United States
Sponsor
University of Pittsburgh
View Trial →
NCT06163131
Recruiting

The Effect of Treatment of Emphysema With Endobronchial Valves on the Diaphragm Mobility

Enrollment
35 pts
Location
Denmark
Sponsor
Aarhus University Hospital
View Trial →
NCT07274631
Recruiting

A Cohort for Inflammatory Respiratory Diseases: From Phenotyping to Personalised Medicine

Enrollment
470 pts
Location
France
Sponsor
CHU de Reims
View Trial →
NCT06974981
Recruiting

Leveraging Lung Cancer Screening to Optimize Screening Outcomes and COPD Management: COPD in LCS Registry

Enrollment
420 pts
Location
United States
Sponsor
Sidney Kimmel Comprehensive Ca...
View Trial →
NCT05746039 Phase 1, Phase 2
Recruiting

Feasibility of Semaglutide in Advanced Lung Disease

Enrollment
8 pts
Location
United States
Sponsor
University of Pennsylvania
View Trial →
NCT06491043 Phase 2
Recruiting

Treatment of Chronic Obstructive Pulmonary Disease by Infusion of Allogenic Mesenchymal Stem Cells

Enrollment
90 pts
Location
Taiwan
Sponsor
Meribank Biotech Co., Ltd.
View Trial →
NCT05553223
Recruiting

Micro-doses of Physical Activity for COPD

Enrollment
20 pts
Location
Canada
Sponsor
University of British Columbia
View Trial →
NCT05061368 Phase 2
Recruiting

Oral Sildenafil for Exercise Capacity, Dyspnea and Cardiopulmonary Function in COPD

Enrollment
160 pts
Location
Canada
Sponsor
University of Alberta
View Trial →